✨ #REDEFINE2: #Cagrilintide + #semaglutide significantly reduce body weight. “We’re looking for more choices & highly efficacious #weightloss therapies for the clinic” says PI Prof. Melanie Davies in a new #ExpertInsights episode & Journal Read.

Watch/read 👉 easd-elearning.eu/horizons/

#Diabetes

CagriSema may REDEFINE weight loss treatment Combination treatment with cagrilintide and semaglutide significantly reduces bodyweight in adults living with overweight or obesity, with or without type 2 diabetes.

From #ADA2025 - Combination treatment with #cagrilintide and #semaglutide significantly reduces bodyweight in adults living with overweight or #obesity, with or without type 2 #diabetes.

Full story 👇
buff.ly/eIVl1fx

Cagrilintide and semaglutide together drive record weight loss in global trial A 68-week phase 3 trial found that coadministered cagrilintide and semaglutide led to significant and clinically meaningful weight loss in adults with obesity but no diabetes. The combination outperfo...

Cagrilintide and semaglutide together drive record weight loss in global trial www.news-medical.net/news/2025062... #Obesity #WeightLoss #ClinicalTrial #Cagrilintide #Semaglutide #Health #Cardiometabolic @nejm.org

#PressRelease

In #Redefine1 RCT of 3417 ppl w overweight/obesity & one/more comorbidities
🔺#cagrisema 2.4/2.4 mg sc/wk -> more wt loss than #cagrilintide 2.4mg or #semaglutide 2.4mg or placebo at 68 wks even though lower % reached target dose than w each component
https://www.novonordisk.com/news-and-media/ne…